The biopharmaceutical sector is expanding twice as fast as traditional drug manufacturing, and currently accounts for 20 percent of the pharmaceutical industry.1,2 Biotechnology companies are therefore under increasing pressure to maintain a rapid pace of development, while providing trackable documentation to…
Scottish CRDMO Ingenza has secured innovation funding to adapt its codABLE™ machine learning platform to precisely control recombinant protein expression in the industrial yeast Pichia pastoris. This game-changing project will accelerate the development of therapeutics, enzymes and other proteins by harnessing machine learning to…
Recombinant protein production is an important technique for generating large quantities of proteins in a variety of pharmaceutical, agricultural and industrial applications. It is widely used in the development and manufacture of drugs – such as insulin, growth factors and…
Edinburgh, Scotland – Ingenza, a dynamic CDMO and leader in engineering biology, is pleased to announce its strategic partnership with Opvia, a Quality Management Systems (QMS) provider. This partnership is driven by Ingenza’s commitment to enhance and centralise its quality…
Ingenza is proud to announce that our molecular biology team recently co-authored a groundbreaking research paper published in Applied Microbiology International. The study addressed current challenges in producing recombinant proteins in the methylotrophic yeast Pichia pastoris. P. pastoris is a…
The entire team at Ingenza is sending heartfelt congratulations to our very own Dr Alison Arnold as she celebrates an amazing 20 years of working with us! Alison Arnold, PhD, joined Ingenza in 2003 as Senior Scientist for our fermentation…
Ingenza’s novel ester-impregnated pH strips significantly improve the accuracy of locating nasogastric (NG) feeding tubes in a study carried out in 10 NHS hospitals, as published in Diagnostic and Prognostic Research. The peer-reviewed paper found the innovative test to be…
The fast-moving pace of the biopharmaceutical sector and the diversity of potential therapeutic targets are putting the industry’s resources under ever-growing pressure. Each new cell line or manufacturing technology requires dedicated time, space and staff – not to mention in-house…
Engineering biology uses engineering principles to manipulate biological systems with the aim of creating useful products and addressing diverse challenges in human health and the global environment. At Ingenza, we rely on biological engineering to help our customers create numerous…
Ingenza and Phibro Ethanol – a division of Phibro Animal Health Corporation – have joined forces to engineer a novel yeast strain that will increase yield in the commercial production of bioethanol under both challenging and conventional environmental conditions, further driving the switch to clean biofuels. This latest innovation –…